Cargando…
Flavoprotein Fluorescence Correlation with Visual Acuity Response in Patients Receiving Anti-VEGF Injection for Diabetic Macular Edema
Anti-VEGF treatment of diabetic macular edema (DME) complicating diabetic retinopathy (DR) has greatly improved structural and visual outcomes for patients with diabetes mellitus. However, up to 50% of patients are either nonresponsive or refractory to anti-VEGF treatment (no improvement in BCVA or...
Autores principales: | Andrade Romo, Jorge S., Lynch, Giselle, Liu, Kevin, Kim, Daniel, Jansen, Michael, Field, Matthew G., Elner, Victor M., Rosen, Richard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109491/ https://www.ncbi.nlm.nih.gov/pubmed/30159113 http://dx.doi.org/10.1155/2018/3567306 |
Ejemplares similares
-
Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
por: Zhang, Ying, et al.
Publicado: (2022) -
Relationship Between Macular Thickness and Visual Acuity in the
Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic
Review
por: Wang, Patrick, et al.
Publicado: (2022) -
Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema
por: Zaidi, Zafar A., et al.
Publicado: (2009) -
Relevance of Visual Acuity Measurement for Therapeutic Decisions in Diabetic Macular Edema
por: Mathis, Thibaud, et al.
Publicado: (2023) -
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
por: Veloso, Carlos E., et al.
Publicado: (2021)